asia-pacific
(12)
The Agency That Learned to Translate Science
Strategic Partners Group found its edge in a problem most agencies avoid: making technical, regulated subjects understandable without making them flimsy. Then it turned that narrow specialty into a wider Asian communications platform.
SKC knows your launch shouldn’t start at 2 a.m.
A Seattle airline launch reveals the practical intelligence behind SKC: helping brands cross the Pacific, find the right audience, and give that audience a reason to care.
Investible brings a club to the cap table
The Australian venture firm pairs managed funds with a global syndicate of more than 250 investors. Its wager: the people around a startup can matter as much as the money inside it.
SEEK spent A$180 million to make three job boards think as one
The company that helped move Australian job ads off the newspaper page has rebuilt its machinery across Asia Pacific. Now it wants to earn more of its money from the work that happens after someone clicks Apply.
DayOne Is Turning Three Neighbors Into One Giant Data Center
The Singapore infrastructure company is stitching together land, power and fiber across borders - then exporting the playbook from Southeast Asia to Tokyo and Finland.
The $99-a-Month On-Ramp to Enterprise Software
Jcurve built a business around the awkward moment when accounting software stops being enough. Its answer is an ERP ladder - start small, connect the moving parts, and keep climbing without ripping everything out again.
The 38-Year-Old Company Trying to Give Retail One Memory
Every click, return and last item on a shelf creates data. ETP Group has spent nearly four decades trying to make sure a retailer remembers all of it at once.
Beam Mobility
The Singapore startup that turned the shared e-scooter into a negotiation with city hall - and is now merging its way to more than 100 cities.
MetroResidences
MetroResidences is a Singapore-founded proptech platform that curates furnished serviced apartments and monthly rentals for business travellers, expats and urban professionals across Asia Pacific. Launched in 2014 by James Chua and Lester Kang, it matches corporate tenants needing month-plus stays with quality apartments and layers on hotel-style services like housekeeping, maintenance and front-desk support. Backed by Rakuten Capital and 500 Durians, the company positions itself as a professionally managed alternative to both traditional serviced-residence operators and Airbnb-style listings.
Outsized
Outsized is a curated talent-on-demand platform that connects large enterprises and consulting firms with vetted independent consultants, subject-matter experts, interims and fractional professionals across Asia-Pacific, Africa and the Middle East. Founded in 2016 and focused on financial services, it pairs management-consulting rigor with deep industry domain expertise, handling matching, contracting, invoicing and payments so clients can staff transformation, risk, data and digital projects in days rather than months.
Plover
Plover is a Singapore-based corporate travel and technology company that simplifies business travel through a wholly owned, cloud-based SaaS platform. Founded in 2017, it combines a full-service travel management company (TMC) with proprietary apps for travel booking, expense management, and workspace management. Plover describes itself as builder of Asia's first fully integrated corporate travel, expense and workspace platform, offering GDS, NDC and Direct Connect airline content plus global hotel aggregators to corporates and travel agencies across the Asia Pacific region.
HiRO - Harvest Integrated Research Organization
HiRO (Harvest Integrated Research Organization) is a full-service, globally oriented clinical research organization founded in 2020 that helps biotech companies run clinical trials across borders. Positioning itself as an 'integrated' rather than a traditional 'contract' research organization, HiRO connects Asian biotechs seeking trials outside their region with US and European sponsors wanting to run studies in Asia. Backed by a tens-of-millions-of-dollars Series A led by OrbiMed and built out through three CRO acquisitions, it offers end-to-end services from preclinical strategy to regulatory submission, with deep expertise in oncology and rare disease.